Immucell (ICCC) EPS (Basic) (2016 - 2025)
Historic EPS (Basic) for Immucell (ICCC) over the last 16 years, with Q3 2025 value amounting to -$0.02.
- Immucell's EPS (Basic) rose 7777.78% to -$0.02 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.28, marking a year-over-year increase of 15600.0%. This contributed to the annual value of -$0.26 for FY2024, which is 6511.62% up from last year.
- Per Immucell's latest filing, its EPS (Basic) stood at -$0.02 for Q3 2025, which was up 7777.78% from $0.06 recorded in Q2 2025.
- Immucell's 5-year EPS (Basic) high stood at $0.16 for Q1 2025, and its period low was -$0.3 during Q1 2023.
- Moreover, its 5-year median value for EPS (Basic) was -$0.06 (2021), whereas its average is -$0.06.
- Per our database at Business Quant, Immucell's EPS (Basic) crashed by 230540.45% in 2022 and then skyrocketed by 36666.67% in 2025.
- Quarter analysis of 5 years shows Immucell's EPS (Basic) stood at $0.01 in 2021, then crashed by 2305.4% to -$0.22 in 2022, then soared by 31.68% to -$0.15 in 2023, then skyrocketed by 154.38% to $0.08 in 2024, then plummeted by 125.0% to -$0.02 in 2025.
- Its EPS (Basic) was -$0.02 in Q3 2025, compared to $0.06 in Q2 2025 and $0.16 in Q1 2025.